Target intelligence / Profile preview

Streptococcal cysteine proteinase (SpeB)

Target
SpeB
Molecular classification
Enzyme, Protease, Cysteine protease, Virulence factor
01

Overview

Streptococcal cysteine proteinase (SpeB) is a secreted bacterial enzyme produced by *Streptococcus pyogenes* (group A streptococcus) that plays a central role in pathogenesis by broadly degrading host and bacterial proteins[1][3][5]. SpeB is produced as a 40-kDa zymogen and activated to a 28-kDa mature protease by autocatalytic cleavage or protease assistance[1]. It exhibits proteolytic activity against plasma proteins (e.g., vitronectin, fibronectin, fibrinogen), all major human immunoglobulin isotypes (with a papain-like specificity for the IgG hinge), and proinflammatory mediators (e.g., converts pro-IL-1β to active IL-1β, releases bradykinin from H-kininogen)[1][5][7]. These activities contribute to immune evasion, tissue invasion, and the broad spectrum of disease associated with *S. pyogenes* infection. SpeB’s role extends beyond host interaction, as it can also degrade bacterial proteins and disrupt the biofilms of co-colonizing organisms such as *Staphylococcus aureus*[2]. Regulation of SpeB is complex and responsive to environmental signals, growth phase, and multiple bacterial regulators[4][8]. Due to its central role in virulence, SpeB is a potential therapeutic target, biomarker for invasive disease, and model for the study of bacterial proteases[6].

Other names
streptopainstreptococcal pyrogenic exotoxin Bstreptococcal erythrogenic toxin BSPE B
02

Mechanism of action

Cleavage of host and bacterial proteins, degradation of immunoglobulins (including IgG, IgA, IgM, IgD, IgE), activation of proinflammatory cytokines (e.g., IL-1β), release of kinins (e.g., bradykinin), biofilm disruption

03

Biological functions

Proteolysis of host and bacterial proteinsImmune evasionActivation of proinflammatory mediatorsDisruption of host tissue barriersDegradation of immunoglobulinsBiofilm disruptionInduction of inflammation
04

Disease associations

Infection, particularly in streptococcal pharyngitis, impetigo, necrotizing fasciitis, streptococcal toxic shock syndrome, sepsis, post-streptococcal glomerulonephritis, acute rheumatic fever
05

Safety considerations

Protease activity may cause nonspecific tissue destruction, contribute to excessive inflammation, and complicate therapeutic targeting due to broad substrate specificity
06

Biomarkers

Elevated SpeB expression or presence in infected tissues or fluids may act as a biomarker for invasive or severe *S. pyogenes* infection

Beyond the preview

Go deeper on Streptococcal cysteine proteinase (SpeB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcal cysteine proteinase (SpeB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call